pBI-CMV1

Mammalian bidirectional promoter vector for constitutively expressing two genes at similar levels.

Sequence Author: Clontech (TaKaRa)

|Download SnapGene Viewer
Explore Over 2.7k Plasmids: Mammalian Expression Vectors | More Plasmid Sets
No matches
StuI (3085) SacI (3072) Eco53kI (3070) EcoRI (3035) AgeI (3029) SacII (3020) ApaI (3015) EcoO109I (3012) PspOMI (3011) BglII (3005) Bsu36I (2999) PstI (2996) XbaI (2986) SspI (2676) EarI (2667) XmnI (2471) ScaI (2352) PvuI (2242) FspI (2094) NmeAIII (2020) BsaI (1933) AhdI (1872) PaeR7I - PspXI - XhoI (1) BtgZI (340) BsaAI - SnaBI (346) NcoI - StyI (366) CMV promoter BamHI (602) PvuII (616) MluI (620) NheI (626) BmtI (630) EagI - NotI (633) BspDI - ClaI (641) HindIII (646) SalI (652) AccI (653) EcoRV (660) PciI (979) NspI (983) DrdI (1087) HaeII (1227) BseYI (1283) PspFI (1287) AlwNI (1395) pBI-CMV1 3114 bp
StuI  (3085)
1 site
A G G C C T T C C G G A
SacI  (3072)
1 site
G A G C T C C T C G A G
Eco53kI  (3070)
1 site
G A G C T C C T C G A G
EcoRI  (3035)
1 site
G A A T T C C T T A A G
AgeI  (3029)
1 site
A C C G G T T G G C C A
SacII  (3020)
1 site
C C G C G G G G C G C C

Efficient cleavage requires at least two copies of the SacII recognition sequence.
ApaI  (3015)
1 site
G G G C C C C C C G G G

ApaI can be used between 25°C and 37°C.
EcoO109I  (3012)
1 site
R G G N C C Y Y C C N G G R

Sticky ends from different EcoO109I sites may not be compatible.
PspOMI  (3011)
1 site
G G G C C C C C C G G G
BglII  (3005)
1 site
A G A T C T T C T A G A
Bsu36I  (2999)
1 site
C C T N A G G G G A N T C C

Sticky ends from different Bsu36I sites may not be compatible.
PstI  (2996)
1 site
C T G C A G G A C G T C
XbaI  (2986)
1 site
T C T A G A A G A T C T
SspI  (2676)
1 site
A A T A T T T T A T A A
EarI  (2667)
1 site
C T C T T C N G A G A A G N N N N

Cleavage may be enhanced when more than one copy of the EarI recognition sequence is present.
Sticky ends from different EarI sites may not be compatible.
XmnI  (2471)
1 site
G A A N N N N T T C C T T N N N N A A G
ScaI  (2352)
1 site
A G T A C T T C A T G A
PvuI  (2242)
1 site
C G A T C G G C T A G C
FspI  (2094)
1 site
T G C G C A A C G C G T
NmeAIII  (2020)
1 site
G C C G A G ( N ) 18-19 N N C G G C T C ( N ) 18-19

Efficient cleavage requires at least two copies of the NmeAIII recognition sequence.
Sticky ends from different NmeAIII sites may not be compatible.
For full activity, add fresh S-adenosylmethionine (SAM).
BsaI  (1933)
1 site
G G T C T C N C C A G A G N ( N ) 4

Sticky ends from different BsaI sites may not be compatible.
BsaI can be used between 37°C and 50°C.
AhdI  (1872)
1 site
G A C N N N N N G T C C T G N N N N N C A G

The 1-base overhangs produced by AhdI may be hard to ligate.
Sticky ends from different AhdI sites may not be compatible.
PaeR7I  (1)
1 site
C T C G A G G A G C T C

PaeR7I does not recognize the sequence CTCTCGAG.
PspXI  (1)
1 site
V C T C G A G B B G A G C T C V
XhoI  (1)
1 site
C T C G A G G A G C T C
BtgZI  (340)
1 site
G C G A T G ( N ) 10 C G C T A C ( N ) 10 ( N ) 4

Sticky ends from different BtgZI sites may not be compatible.
After cleavage, BtgZI can remain bound to DNA and alter its electrophoretic mobility.
BtgZI is typically used at 60°C, but is 75% active at 37°C.
BsaAI  (346)
1 site
Y A C G T R R T G C A Y
SnaBI  (346)
1 site
T A C G T A A T G C A T
NcoI  (366)
1 site
C C A T G G G G T A C C
StyI  (366)
1 site
C C W W G G G G W W C C

Sticky ends from different StyI sites may not be compatible.
BamHI  (602)
1 site
G G A T C C C C T A G G

After cleavage, BamHI-HF® (but not the original BamHI) can remain bound to DNA and alter its electrophoretic mobility.
PvuII  (616)
1 site
C A G C T G G T C G A C
MluI  (620)
1 site
A C G C G T T G C G C A
NheI  (626)
1 site
G C T A G C C G A T C G
BmtI  (630)
1 site
G C T A G C C G A T C G
EagI  (633)
1 site
C G G C C G G C C G G C
NotI  (633)
1 site
G C G G C C G C C G C C G G C G
BspDI  (641)
1 site
A T C G A T T A G C T A
ClaI  (641)
1 site
A T C G A T T A G C T A
HindIII  (646)
1 site
A A G C T T T T C G A A
SalI  (652)
1 site
G T C G A C C A G C T G
AccI  (653)
1 site
G T M K A C C A K M T G

Efficient cleavage with AccI requires ≥13 bp on each side of the recognition sequence.
Sticky ends from different AccI sites may not be compatible.
EcoRV  (660)
1 site
G A T A T C C T A T A G

EcoRV is reportedly more prone than its isoschizomer Eco32I to delete a base after cleavage.
PciI  (979)
1 site
A C A T G T T G T A C A

PciI is inhibited by nonionic detergents.
NspI  (983)
1 site
R C A T G Y Y G T A C R
DrdI  (1087)
1 site
G A C N N N N N N G T C C T G N N N N N N C A G

Sticky ends from different DrdI sites may not be compatible.
HaeII  (1227)
1 site
R G C G C Y Y C G C G R
BseYI  (1283)
1 site
C C C A G C G G G T C G

After cleavage, BseYI can remain bound to DNA and alter its electrophoretic mobility.
PspFI  (1287)
1 site
C C C A G C G G G T C G
AlwNI  (1395)
1 site
C A G N N N C T G G T C N N N G A C

Sticky ends from different AlwNI sites may not be compatible.
AmpR
1799 .. 2659  =  861 bp
286 amino acids  =  31.5 kDa
2 segments
   Segment 2:  
   1799 .. 2590  =  792 bp
   263 amino acids  =  28.9 kDa
Product: β-lactamase
confers resistance to ampicillin, carbenicillin, and related antibiotics
AmpR
1799 .. 2659  =  861 bp
286 amino acids  =  31.5 kDa
2 segments
   Segment 1:  signal sequence  
   2591 .. 2659  =  69 bp
   23 amino acids  =  2.6 kDa
Product: β-lactamase
confers resistance to ampicillin, carbenicillin, and related antibiotics
AmpR
1799 .. 2659  =  861 bp
286 amino acids  =  31.5 kDa
2 segments
Product: β-lactamase
confers resistance to ampicillin, carbenicillin, and related antibiotics
ori
1040 .. 1628  =  589 bp
high-copy-number ColE1/pMB1/pBR322/pUC origin of replication
ori
1040 .. 1628  =  589 bp
high-copy-number ColE1/pMB1/pBR322/pUC origin of replication
CMV enhancer
67 .. 370  =  304 bp
human cytomegalovirus immediate early enhancer
CMV enhancer
67 .. 370  =  304 bp
human cytomegalovirus immediate early enhancer
CMV promoter
371 .. 574  =  204 bp
human cytomegalovirus (CMV) immediate early promoter
CMV promoter
371 .. 574  =  204 bp
human cytomegalovirus (CMV) immediate early promoter
AmpR promoter
2660 .. 2764  =  105 bp
AmpR promoter
2660 .. 2764  =  105 bp
SV40 poly(A) signal
777 .. 858  =  82 bp
SV40 polyadenylation signal
SV40 poly(A) signal
777 .. 858  =  82 bp
SV40 polyadenylation signal
SV40 poly(A) signal
2797 .. 2878  =  82 bp
SV40 polyadenylation signal
SV40 poly(A) signal
2797 .. 2878  =  82 bp
SV40 polyadenylation signal
MCS 1
602 .. 663  =  62 bp
multiple cloning site 1
MCS 1
602 .. 663  =  62 bp
multiple cloning site 1
MCS 2
2986 .. 3040  =  55 bp
multiple cloning site 2
MCS 2
2986 .. 3040  =  55 bp
multiple cloning site 2
minimal CMV promoter
3069 .. 3106  =  38 bp
human cytomegalovirus (CMV) immediate early promoter
minimal CMV promoter
3069 .. 3106  =  38 bp
human cytomegalovirus (CMV) immediate early promoter
ORF:  1929 .. 2195  =  267 bp
ORF:  88 amino acids  =  9.2 kDa
ORF:  1799 .. 2659  =  861 bp
ORF:  286 amino acids  =  31.5 kDa
Click here to try SnapGene

Download pBI-CMV1.dna file

SnapGene

SnapGene is the easiest way to plan, visualize and document your everyday molecular biology procedures

  • Fast accurate construct design for all major molecular cloning techniques
  • Validate sequenced constructs using powerful alignment tools
  • Customize plasmid maps with flexible annotation and visualization controls
  • Automatically generate a rich graphical history of every edit and procedure

SnapGene Viewer

SnapGene Viewer is free software that allows molecular biologists to create, browse, and share richly annotated sequence files.

  • Gain unparalleled visibility of your plasmids, DNA and protein sequences
  • Annotate features on your plasmids using the curated feature database
  • Store, search, and share your sequences, files and maps

Individual Sequences & Maps

The maps, notes, and annotations in the zip file on this page are copyrighted material. This material may be used without restriction by academic, nonprofit, and governmental entities, except that the source must be cited as ’’www.snapgene.com/resources’’. Commercial entities must contact GSL Biotech LLC for permission and terms of use.

Discover the most user-friendly molecular biology experience.